학술논문

Social Genomics of Methamphetamine Use, HIV Viral Load, and Social Adversity
Document Type
article
Source
Annals of Behavioral Medicine. 56(9)
Subject
Health Sciences
Psychology
Substance Misuse
Infectious Diseases
Genetics
Prevention
Drug Abuse (NIDA only)
Clinical Research
Behavioral and Social Science
Sexual and Gender Minorities (SGM/LGBT*)
HIV/AIDS
Mental Health
Methamphetamine
Infection
Good Health and Well Being
Genomics
HIV Infections
Homosexuality
Male
Humans
Leukocytes
Mononuclear
Male
Sexual and Gender Minorities
Viral Load
Gene expression
Immune system
Transcriptome
HIV
Viral load
Medical and Health Sciences
Education
Psychology and Cognitive Sciences
Public Health
Health sciences
Language
Abstract
BackgroundSocial genomics has demonstrated altered inflammatory and type I interferon (IFN) gene expression among people experiencing chronic social adversity. Adverse social experiences such as discrimination and violence are linked to stimulant misuse and HIV, conditions that dysregulate inflammatory and innate antiviral responses, leading to increased HIV viral replication and risk of chronic diseases.PurposeWe aimed to determine whether methamphetamine (MA) use, unsuppressed HIV viral load (VL) (≥200 c/mL), and experienced intimate partner violence (IPV) (past 12 months) predicted inflammatory and type I IFN gene expression in HIV-positive Black and Latinx men who have sex with men (MSM).MethodsParticipants were 147 HIV-positive Black and Latinx MSM recruited from the mSTUDY, a cohort of 561 MSM aged 18-45 in Los Angeles, CA, of whom half are HIV-positive and substance-using. Transcriptomic measures of inflammatory and type I IFN activity were derived from RNA sequencing of peripheral blood mononuclear cells and matched to urine drug tests, VL, and survey data across two time points 12 months apart. Analysis used linear random intercept modeling of MA use, unsuppressed VL, and experienced IPV on inflammatory and type I IFN expression.ResultsIn adjusted models, MA use predicted 27% upregulated inflammatory and 31% upregulated type I IFN expression; unsuppressed VL predicted 84% upregulated type I IFN but not inflammatory expression; and experienced IPV predicted 31% upregulated inflammatory and 26% upregulated type I IFN expression.ConclusionsIn Black and Latinx MSM with HIV, MA use, unsuppressed VL, and experienced IPV predicted upregulated social genomic markers of immune functioning.